InterVenn Biosciences Partners with Aranscia to Accelerate Commercialization of GlycoKnow™ Non-Invasive Ovarian Cancer Diagnostic Test
InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions, today announced a partnership where Aranscia technical and laboratory resources will help to facilitate clinical workflows and expand the availability of InterVenn’s flagship GlycoKnow™ Ovarian cancer diagnostic test.
Niron Magnetics and Bimotal Join Forces to Power the Future of Motion
Niron Magnetics, a leading manufacturer of high-performance rare-earth-free Iron Nitride permanent magnets, and Bimotal, a leader in ultra-compact, high-torque motor systems, are collaborating to develop next-generation electric motor designs for mobility and robotics applications.
Navier Raises $5.6M to Deploy Agent-Driven Engineering, the Next Engineering Unlock After CAD and Simulation
Navier, which builds autonomous engineering teams for hardware design and development, today announced $5.6 million in seed funding and its launch from stealth. The round includes participation from GV (Google Ventures), HCVC, and Y Combinator.
Niron Magnetics and Moog Inc. Partner to Produce Rare-Earth-Free Actuator Designs for Defense Applications
Niron Magnetics, a leading manufacturer of high-performance rare-earth-free permanent magnets, and Moog Inc. (NYSE: MOG.A and MOG.B), a worldwide designer, manufacturer, and systems integrator of high-performance precision motion and fluid controls and control systems, are collaborating to bring advanced actuator solutions for guided munitions systems to market.
Codetta Bio™ Expands Global Commercial Leadership to Accelerate Worldwide Adoption of the Concerto™ System
Codetta Bio™, a leading innovator in multi-omic solutions that integrate ultrasensitive protein quantitation with simultaneous analysis of nucleic acids (RNA and DNA), today announced a significant expansion of its global commercial organization. This strategic move strengthens the company’s ability to meet growing demand for its Concerto™ system as Codetta transitions from its Technology Access Program (TAP) to full commercial launch.
South 8 Technologies Secures $11M in Additional Funding to Accelerate LiGas Battery Production for Defense and Aerospace
South 8 Technologies, the developer of LiGas®, the world’s first liquefied gas electrolyte for lithium-ion batteries, today announced an $11 million follow-on funding round co-led by the venture arm of W. L. Gore & Associates (Gore) and Lockheed Martin Ventures. The capital will accelerate commercialization of South 8’s LiGas battery cells for aerospace and defense applications that require reliable energy in the harshest environments.
6K Additive Secures A$48 Million Through Initial Public Offering on the Australian Stock Exchange
6K Additive, a global leader in advanced metal powders and alloy additions, today announced the successful completion of its IPO on the Australian Stock Exchange (ASX), raising A$48m at an offer price of A$1.00 per CDI (Offer Price). At the Offer Price, 6K Additive has an initial market capitalization of approximately A$267m and an enterprise value of approximately A$206m. The Company’s CDIs will trade on ASX under the ticker symbol 6KA. The IPO attracted strong support from a range of new institutional, family office and sophisticated investors in Australia and overseas, together with existing shareholders. Trusted by leading organizations across aerospace, defense, space, medical, energy, and automotive sectors, 6K Additive plans to use the newly secured capital to support its expansion plan to better serve its growing customer base and broaden its product offerings.
Niron Magnetics CEO Testifies Before Congress on Urgent Action Needed for Rare Earth Alternatives
Jonathan Rowntree, Chief Executive Officer of Niron Magnetics, testified Wednesday before the U.S. House Select Committee on the Chinese CCP, presenting the company’s breakthrough Iron Nitride magnet technology as a solution to reducing America’s critical dependence on rare earth materials.
Medcrypt Achieves 100% FDA Submission Approval Rate and Launches Security Intelligence to Help Mature Medical Device Cybersecurity Program
Medcrypt Inc., the leader in medical device cybersecurity, today announced the launch of Medcrypt Security Intelligence, the industry’s first expert-enhanced software solution for assessing, benchmarking, and advancing cybersecurity program maturity across the medical device lifecycle.
Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments
ImmunoScape Pte. Ltd., an A*STAR spin out backed by Amgen Ventures and EDBi that is developing next-generation TCR-based cancer immunotherapies, today announced an exclusive in-licensing deal with Cue Biopharma Inc. (Nasdaq: CUE) to lead the development of a distinct new class of therapies to attack solid tumor cancers. The deal provides ImmunoScape with exclusive access to Cue Biopharma’s clinical-stage Immuno-STAT® molecules in oncology.